Salarius Pharmaceuticals Inc.

09/27/2024 | Press release | Distributed by Public on 09/27/2024 14:02

Material Event Form 8 K

Item 5.08 Shareholder Director Nominations.
To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.